Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Recruiting × vorasidenib × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cisplatin 85 Carboplatin 81 pembrolizumab 78 Gemcitabine 67 Paclitaxel 66 Docetaxel 61 Capecitabine 47 Oxaliplatin 44 Fluorouracil 44 Radiotherapy 43 Specimen Handling 42 Bevacizumab 40 Magnetic Resonance Spectroscopy 38 Pemetrexed 35 Dexamethasone 35 Cyclophosphamide 35 Drug Therapy 34 Leucovorin 32 Doxorubicin 31 Irinotecan 30 Rituximab 26 Lenalidomide 25 Injections 25 Vincristine 23 Trastuzumab 23 Radiosurgery 21 Radiation 20 Prednisone 20 toripalimab 19 Radiotherapy, Intensity-Modulated 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06809322 2026-02-17

VIGOR

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Astrocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡